Study [reference] | Patient population and location | Numbers of patients with fatal outcome/Number tested | |||
---|---|---|---|---|---|
 |  | Group 1 | Group 2 | Group 3 | Group 4 |
 |  | Gnb+ | Gnb+ | Gnb- | Gnb- |
 |  | Etx+ | Etx- | Etx+ | Etx- |
Pre-defined patient groups: Pediatric | Â | Â | Â | Â | |
Ahmed et al. 2004 [1] | Diarrheal illness, hospitalized | 3/9 | 1/1 | 1/12 | 1/19 |
Casey et al. 1992 [2] | Pediatric cardiac surgery, ICU | 0/1 | ND | 0/15 | 0/8 |
Cooperstock, 1985 [3] | Suspected sepsis, hospitalized | 0/10 | 0/1 | 0/6 | 0/26 |
Klein et al. 1988 [4] | Malnourished children, hospitalized | ND | 0/1 | 0/7 | 0/8 |
Shenep et al. 1988 [5] | Suspected sepsis, hospitalized | 2/9 | 0/1 | 1/3 | 0/13 |
Pre-defined patient groups: Surgery and peri-procedural | Â | Â | Â | Â | |
Bailey et al. 1976 [6] | Obstructive jaundice, hospitalized | 1/1 | ND | 0/12 | 0/11 |
Berger et al. 1995 [7]a | Post-colonoscopy, unspecified location | 0/1 | ND | 0/20 | 0/11 |
Foulis et al. 1982 [8]f | Acute pancreatitis, hospitalized | 1/1 | ND | 2/12 | 1/13 |
Lau et al. 1996 [9]a | Acute cholangitis, hospitalized | 1/8 | 0/3 | 0/20 | 0/9 |
Lumsden et al. 1989 [10] | Percutaneous biliary drainage, hospitalized | 0/1 | ND | 0/13 | 0/7 |
Pre-defined patient groups: Specified infections | Â | Â | Â | Â | |
Brandtzaeg et al. 1989 [11]a | Meningococcal disease, hospitalized | 9/24 | 0/11 | ND | 0/7 |
Brandtzaeg et al. 1996 [12]a | Meningococcal disease, hospitalized | 21/40 | 0/19 | 1/4 | 3/26 |
Butler et al. 1973 [13]b | Plague, hospitalized | 1/2 | ND | 0/7 | 0/1 |
Butler et al. 1976 [14]b | Plague, hospitalized | 0/3 | 0/2 | ND | 0/5 |
Magliulo et al. 1976 [15]c | Salmonellosis, hospitalized | 0/1 | ND | 0/9 | 0/12 |
Magliulo et al. 1976 [15]c, d | Typhoid, hospitalized | 0/8 | 0/4 | 0/1 | 0/1 |
Adinolfi et al. 1987 [16]d | Typhoid, hospitalized | 0/7 | 0/7 | 0/2 | 0/5 |
Suyasa et al. 1995 [17]d | Typhoid, hospitalized | 1/4 | 1/6 | ND | 0/9 |
Pre-defined patient groups: Oncology and transplant patients | Â | Â | Â | Â | |
Bion et al. 1994 [18] | Elective liver transplantation, ICU | 0/1 | 0/1 | 1/31 | 4/19 |
Engervall et al. 1997 [19]a | Febrile, oncology (80% neutropenic), hospitalized | 1/2 | 0/4 | 0/4 | 0/14 |
Hynninen et al. 1995 [20] | Febrile, oncology (43% neutropenic), hospitalized | 0/3 | 1/24 | ND | 10/96 |
Yoshida et al. 1994 [21]a | Febrile, oncology (63% neutropenic), hospitalized | 14/21 | 1/9 | 11/35 | 8/71 |
Pre-defined patient groups: Other | Â | Â | Â | Â | |
Byl et al. 2001 [22]a | Suspected sepsis, hospitalized | 2/8 | 0/4 | 0/3 | 1/12 |
Giamarellos et al. 1999 [23]a | Acute pyelonephritis, hospitalized | 1/3 | 0/9 | 0/4 | 0/9 |
Levin et al. 1972 [24] | Suspected sepsis, hospitalized | 14/20 | 4/14 | 7/16 | 27/168 |
Stumacher et al. 1973 [25] | Suspected bacteremia, hospitalized | 6/28 | 15/37 | 2/18 | 4/34 |
Van Langervelde et al. 2000 [26]a | Febrile hospital admissions, hospitalized | 7/24 | 0/24 | 9/76 | 16/324 |
Adult patients in ICU with sepsis as contemporaneously defined | Â | Â | Â | Â | |
Bates et al. 1998 [27]a | Sepsis syndrome, multi-center cohort, hospitalized | 5/10 | 12/39 | 42/109 | 59/198 |
Billard et al. 1994 [28] | Septic shock, ICU | 5/6 | ND | 1/4 | 4/8 |
Danner et al. 1991 [29]a | Clinically defined septic shock, ICU | 4/11 | 0/8 | 8/32 | 12/49 |
Dofferhoff et al. 1992 [30] | Clinically defined severe sepsis, ICU | 2/4 | 0/2 | 0/6 | 1/6 |
Goldie et al. 1995 [31]a | Sepsis syndrome, ICU | 5/9 | 2/3 | 36/83 | 18/38 |
Guidet et al. 1994 [32]a | Sepsis syndrome, ICU | 13/24 | 4/9 | 14/20 | 18/40 |
Strutz et al. 1999 [33] | Sepsis syndrome, ICU | 1/5 | 3/5 | 5/8 | 4/10 |
Wortel et al. 1992 [34]e | Sepsis syndrome, multi-center cohort, ICU | 6/8 | 4/5 | 2/3 | 13/25 |
Opal et al. 1999 [35] (Low; >20 pg/ml) a, f | Sepsis syndrome, multi-center cohort, ICU | 12/51 | 7/21 | 78/255 | 32/128 |
Opal et al. 1999 [35] (High; >660 pg/ml) a, f | Sepsis syndrome, multi-center cohort, ICU | 21/63 | Â | 84/241 | Â |